Alpha Teknova, Inc. (TKNO) is a Drug manufacturers specialty generic company in the Healthcare sector, listed on Nasdaq.
This page provides the complete earnings calendar, dividend schedule, and financial data for Alpha Teknova, Inc. in 2026. The next earnings report is expected on November 5, 2026.
Alpha Teknova, Inc. beat consensus estimates in its latest earnings report, with EPS of -$0.06 versus an estimate of -$0.0843 and revenue of $12.19 million, exceeding estimates by 11.3%. In the prior quarter both EPS and revenue also came in ahead of expectations.
Dividend calendar
No dividend history available.
EPS (Earnings Per Share)
Revenue
Company profile
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.
